These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
208 related items for PubMed ID: 17477415
1. Review of vascularized bone marrow transplantation: current status and future clinical applications. Gordon CR, Tai CY, Suzuki H, Strande LF, Ramsamooj R, Matthews MS, Black KS, Hewitt CW. Microsurgery; 2007; 27(4):348-53. PubMed ID: 17477415 [Abstract] [Full Text] [Related]
2. Composite vascularized skin/bone transplantation models for bone marrow-based tolerance studies. Ozmen S, Ulusal BG, Ulusal AE, Izycki D, Siemionow M. Ann Plast Surg; 2006 Mar; 56(3):295-300. PubMed ID: 16508361 [Abstract] [Full Text] [Related]
3. Vascularized bone marrow transplantation (VBMT): induction of stable mixed T-cell chimerism and transplantation tolerance in unmodified recipients. Yazdi B, Patel MP, Ramsamooj R, Llull R, Achauer BM, Black KS, Hewitt CW. Transplant Proc; 1991 Feb; 23(1 Pt 1):739-40. PubMed ID: 1990672 [Abstract] [Full Text] [Related]
4. Chimerism induction in vascularized bone marrow transplants augmented with bone marrow cells. Arslan E, Klimczak A, Siemionow M. Microsurgery; 2007 Feb; 27(3):190-9. PubMed ID: 17326192 [Abstract] [Full Text] [Related]
5. Absence of graft-versus-host disease in the isolated vascularized bone marrow transplant. Tai CY, Strande LF, Eydelman R, Sheng X, VanTran JL, Matthews MS, Hewitt CW. Transplantation; 2004 Jan 27; 77(2):316-9. PubMed ID: 14743002 [Abstract] [Full Text] [Related]
7. Vascularized bone marrow transplantation model in rats as an alternative to conventional cellular bone marrow transplantation: preliminary results. Zamfirescu D, Popovicu C, Stefanescu A, Bularda A, Popescu M, Zegrea I, Lanzetta M, Lascar I. Transplant Proc; 2011 Nov 27; 43(9):3549-51. PubMed ID: 22099839 [Abstract] [Full Text] [Related]
8. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease. Nestvold JM, Omdal BK, Dai KZ, Martens A, Benestad HB, Vaage JT, Rolstad B. Transplantation; 2008 Jan 15; 85(1):102-11. PubMed ID: 18192919 [Abstract] [Full Text] [Related]
9. Hurdles to the induction of tolerogenic mixed chimerism. Pilat N, Klaus C, Schwaiger E, Wekerle T. Transplantation; 2009 May 15; 87(9 Suppl):S79-84. PubMed ID: 19424016 [Abstract] [Full Text] [Related]
10. Large-scale preparation of human anti-third-party veto cytotoxic T lymphocytes depleted of graft-versus-host reactivity: a new source for graft facilitating cells in bone marrow transplantation. Aviner S, Yao X, Krauthgamer R, Gan Y, Goren-Arbel R, Klein T, Tabilio A, McMannis JD, Champlin R, Martelli MF, Bachar-Lustig E, Reisner Y. Hum Immunol; 2005 Jun 15; 66(6):644-52. PubMed ID: 15993710 [Abstract] [Full Text] [Related]
11. The anti-tumor effect of allogeneic bone marrow/stem cell transplant without graft vs. host disease toxicity and without a matched donor requirement? Har-Noy M, Slavin S. Med Hypotheses; 2008 Jun 15; 70(6):1186-92. PubMed ID: 18054441 [Abstract] [Full Text] [Related]
12. Vascularized bone marrow transplantation: A new surgical approach using isolated femoral bone/bone marrow. Suzuki H, Patel N, Matthews M, DelRossi AJ, Doolin EJ, Hewitt CW. J Surg Res; 2000 Apr 15; 89(2):176-83. PubMed ID: 10729247 [Abstract] [Full Text] [Related]
13. Vascularized bone marrow transplanted in orthotopic hind-limb stimulates hematopoietic recovery in total-body-irradiated rats. Janczewska S, Ziolkowska A, Interewicz B, Majewski T, Olszewski WL, Lukomska B. Transpl Int; 2000 Apr 15; 13 Suppl 1():S541-6. PubMed ID: 11112069 [Abstract] [Full Text] [Related]
14. Effect of posttransplant cyclosporine treatment on the development of syngeneic GVHD in recipients of UV-B irradiated bone marrow cells. Ohajekwe OA, Hardy MA, Oluwole SF. Transplant Proc; 1995 Feb 15; 27(1):1385. PubMed ID: 7878922 [No Abstract] [Full Text] [Related]
15. Multilineage amplification of graft-vs-host disease-resistant chimerism following rat vascularized bone marrow allotransplantation. Llull R, Murase N, Demetris AJ, Ye Q, Manez R, Starzl TE. Transplant Proc; 1995 Aug 15; 27(4):2363-4. PubMed ID: 7544504 [No Abstract] [Full Text] [Related]
16. Co-infusion of donor bone marrow with host mesenchymal stem cells treats GVHD and promotes vascularized skin allograft survival in rats. Aksu AE, Horibe E, Sacks J, Ikeguchi R, Breitinger J, Scozio M, Unadkat J, Feili-Hariri M. Clin Immunol; 2008 Jun 15; 127(3):348-58. PubMed ID: 18387852 [Abstract] [Full Text] [Related]
17. Recovery from established graft-vs-host disease achieved by bone marrow transplantation from a third-party allogeneic donor. Taniguchi Y, Yoshihara S, Hoshida Y, Inoue T, Fujioka T, Ikegame K, Kawakami M, Masuda T, Aozasa K, Kawase I, Ogawa H. Exp Hematol; 2008 Sep 15; 36(9):1216-25. PubMed ID: 18599183 [Abstract] [Full Text] [Related]
18. Induction of tolerance in organ recipients by hematopoietic stem cell transplantation. Ophir E, Reisner Y. Int Immunopharmacol; 2009 Jun 15; 9(6):694-700. PubMed ID: 19150657 [Abstract] [Full Text] [Related]
19. Combined procedure of vascularized bone marrow transplantation and mesenchymal stem cells graft - an effective solution for rapid hematopoietic reconstitution and prevention of graft-versus-host disease. Coliţă A, Coliţă A, Zamfirescu D, Lupu AR. Med Hypotheses; 2012 Sep 15; 79(3):302-3. PubMed ID: 22677297 [Abstract] [Full Text] [Related]
20. Development of stable mixed T cell chimerism and transplantation tolerance without immune modulation in recipients of vascularized bone marrow allografts. Hewitt CW, Ramsamooj R, Patel MP, Yazdi B, Achauer BM, Black KS. Transplantation; 1990 Nov 15; 50(5):766-72. PubMed ID: 2238052 [Abstract] [Full Text] [Related] Page: [Next] [New Search]